University of Colorado Denver School of Public Affairs

The Rocky Mountain ADA Center Names Tess Stanton as Training Administrator

Retrieved on: 
Monday, January 9, 2023
Vocational rehabilitation, Disability, Rocky Mountains, National Network, ADA, Stanton, Organization, Tess, Privacy, Communication, George Mason University Civil Rights Law Journal, University, University of Colorado Denver School of Public Affairs, Disability discrimination act

COLORADO SPRINGS, Colo., Jan. 9, 2023 /PRNewswire-PRWeb/ -- The Rocky Mountain ADA Center (RMADAC), a member of the National Network of ADA Centers, is pleased to announce Tess Stanton as its Training Administrator.

Key Points: 
  • Center provides information dissemination, training and additional services pertaining to the Americans with Disabilities Act to Colorado, Montana, North Dakota, South Dakota, and Utah
    COLORADO SPRINGS, Colo., Jan. 9, 2023 /PRNewswire-PRWeb/ -- The Rocky Mountain ADA Center ( RMADAC ), a member of the National Network of ADA Centers, is pleased to announce Tess Stanton as its Training Administrator.
  • With capacity to assist more organizations in 2023, Stanton looks to expand the center's training program in 2023 with 65-75 training sessions next year.
  • In addition to leading training initiatives for the RMADAC, Stanton acts as its podcast, Adventures in Accessibility , host and producer.
  • Stanton also acts as public media spokesperson for the Rocky Mountain ADA Center.

Exo Therapeutics Appoints Nagesh Mahanthappa as Executive Chair

Retrieved on: 
Wednesday, January 4, 2023
Health, Clinical Trials, Research, Pharmaceutical, Science, Biotechnology, IPO, Babson College, Vesicle (biology and chemistry), Harvard Medical School, California Institute for Quantitative Biosciences, Therapy, Vertex, Corporation, Interim, Alnylam Pharmaceuticals, Vice president, MBA, Acquisition, Ávila, University, University of Colorado Denver School of Public Affairs, Exo, Nagesh, Doctor of Philosophy, Chemistry, Neuroscience, Biology

Exo Therapeutics, Inc. , a company pioneering the use of enzymatic exosites to address intractable drug targets, today announced the appointment of Nagesh Mahanthappa, PhD, to Executive Chair.

Key Points: 
  • Exo Therapeutics, Inc. , a company pioneering the use of enzymatic exosites to address intractable drug targets, today announced the appointment of Nagesh Mahanthappa, PhD, to Executive Chair.
  • “The ExoSight™ platform has tremendous potential to be applied across a wide range of diseases and therapeutic targets,” said Dr. Mahanthappa.
  • “It’s an honor to join Exo as Executive Chair at this exciting time and guide the advancement of our best- and first-in-class programs towards the clinic.”
    Dr. Mahanthappa has served on Exo’s Board of Directors since March 2021 before being appointed Executive Chair.
  • “We are thrilled that Nagesh is stepping into the role of Executive Chair at this important time in the company’s development,” said Dorothy Lou Bailey, COO and Interim President at Exo.

MARCH OF DIMES AWARDS PATRICIA HUNT, PHD THE 2022 PRIZE IN DEVELOPMENTAL BIOLOGY FOR RESEARCH ON THE IMPACT OF AGE AND ENVIRONMENTAL EXPOSURES ON PRENATAL DEVELOPMENT AND PREGNANCY

Retrieved on: 
Tuesday, December 20, 2022
March of Dimes Prize in Developmental Biology, Michigan State University, Child, Family, Education, Egg, Case Western Reserve University, Health, Nobel Prize, Faculty, University, Society, Risk, Pregnancy, BPA, Emory University, Nobel Prize in Physiology or Medicine, Cell division, Developmental biology, Developmental Biology (journal), Mouse, Regent, Multimedia, Jackson, Plastic, University of Hawaiʻi, Meiosis, Mother, Reproductive biology, Ageing, Pediatrics, Science, Doctor of Philosophy, Washington State University, MS, Research, BS, University of Colorado Denver School of Public Affairs, Medicine, Dime, Genetics, Physiology

This annual award honors an outstanding scientist who has advanced the science that underlies our understanding of pregnancy, birth and prenatal development.

Key Points: 
  • This annual award honors an outstanding scientist who has advanced the science that underlies our understanding of pregnancy, birth and prenatal development.
  • It carries a $150,000 award and is part of March of Dimes' research strategy to address the multi-faceted nature of the maternal and child health crisis.
  • To date, six recipients have gone on to win the Nobel Prize in Physiology or Medicine.
  • Throughout her career, Dr. Hunt has focused on understanding how prenatal development is impacted by aging, mistakes in meiosis, and environmental contaminants.

Recipients of Advanced Energy’s 2023 STEM Scholarship Awarded Tuition Support, Internship Opportunities and Professional Mentoring

Retrieved on: 
Thursday, December 15, 2022
University, Data Management, Education, Technology, Manufacturing, Semiconductor, Alternative Energy, Energy, Engineering, Hardware, Continuing, Ministry of Education (Malaysia), Buffalo buffalo Buffalo buffalo buffalo buffalo Buffalo buffalo, Buffalo, University of Colorado Boulder, Mathematics, University of Colorado Denver School of Public Affairs, University at Buffalo, Science, Research, Rochester Institute of Technology, University of Minnesota, San Jose State University, Telecommunication, Advanced Energy, Energy, Multimedia, California Polytechnic State University, University, Education, Colorado State University, Engineering, Student, San Luis Obispo, California, Tutoring, Management, Risk management, STEM

Advanced Energy (Nasdaq: AEIS) a global leader in highly engineered, precision power conversion, measurement and control solutions launched its 2023 Advanced Energy STEM Diversity Scholarship Program.

Key Points: 
  • Advanced Energy (Nasdaq: AEIS) a global leader in highly engineered, precision power conversion, measurement and control solutions launched its 2023 Advanced Energy STEM Diversity Scholarship Program.
  • In addition to providing each recipient a $20,000 grant towards tuition cost, benefits include professional mentoring and internship opportunities at Advanced Energy.
  • View the full release here: https://www.businesswire.com/news/home/20221215005104/en/
    Recipients of Advanced Energys 2023 STEM Scholarship Awarded Tuition Support, Internship Opportunities and Professional Mentoring (Photo: Business Wire)
    The technology industrys success depends on new ideas coming from a diverse, innovative and entrepreneurial workforce, and we need to be intentional about reaching out to underrepresented groups in the STEM field, said Randy Heckman, Chief Technology Officer at Advanced Energy.
  • Our STEM Diversity Scholarship Program aims to expand the talent pipeline and develop students from diverse backgrounds into workforce-ready professionals.

Telstra Taps Katy Greenfield to Lead Customer Solutions for the Americas

Retrieved on: 
Wednesday, November 30, 2022
Technology, Internet, Other Technology, Telecommunications, Internet, IP, Zayo Group, University, Multimedia, University of Colorado Denver School of Public Affairs, Information technology, City, Commerce, Telecommunication, Business administration, Investment, Engineering, Management, Telstra, Science

Telstra has named Katy Greenfield as Vice President of Customer Solutions for the Americas.

Key Points: 
  • Telstra has named Katy Greenfield as Vice President of Customer Solutions for the Americas.
  • She will lead a specialized team working directly with enterprises across the region to develop customized network connectivity products and services.
  • View the full release here: https://www.businesswire.com/news/home/20221130005444/en/
    Organizations already have enough challenges managing their business, customers and employees, said Greenfield.
  • Katy is the perfect choice to lead our highest-priority technology initiatives designed to complement enterprise operations and network infrastructure investments, said Drake.

Stephens Hires Michael Scialla for Energy Equity Research

Retrieved on: 
Tuesday, November 29, 2022
Finance, Energy, Professional Services, Asset Management, Other Energy, Financial Conduct Authority, Colorado School of Mines, History, University, Geophysics, University of Colorado Denver School of Public Affairs, Stephens Inc., Arthur Street Cemetery, Registered, Research, Chevron, Master, Management, Stifel, Science

Stephens, an independent financial services firm, today announced Michael Scialla has joined the firm as a Managing Director and will lead energy equity research coverage.

Key Points: 
  • Stephens, an independent financial services firm, today announced Michael Scialla has joined the firm as a Managing Director and will lead energy equity research coverage.
  • Michael is a consummate professional with deep knowledge of the energy sector that spans finance and Geophysics, said Executive Vice President, Nik Fisken, Stephens Head of Institutional Equities and Research.
  • Mr. Scialla has a distinguished career in energy research.
  • Its an honor to join the Stephens team which has a notable history in this sector, said Mr. Scialla.

Earable® Neuroscience Launches FRENZ™ Brainband globally, following the recognition at CES Innovation Awards 2023

Retrieved on: 
Thursday, November 17, 2022
Wearable technology, History, Electronics, NIC, National Innovation Center, University, Ministry, University of Colorado Denver School of Public Affairs, Neuroscience, Sleep, Consumer Electronics Show, CES, EEG, MPI, Tax, Ministry of Planning and Investment (Vietnam), Relaxation, Consumer electronics, Medical imaging

BOULDER, Colo., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Earable Neuroscience has announced that the FRENZ Brainband will be showcased at the Consumer Electronics Show (CES 2023) and has been awarded the CES 2023 Innovation Awards for the Wearable Technology category.

Key Points: 
  • BOULDER, Colo., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Earable Neuroscience has announced that the FRENZ Brainband will be showcased at the Consumer Electronics Show (CES 2023) and has been awarded the CES 2023 Innovation Awards for the Wearable Technology category.
  • FRENZ by Earable Neuroscience is the world's most accurate consumer brainband that can track and stimulate brain activity for better sleep, focus, and relaxation.
  • The recognition from the industry leaders of consumer electronics at the CES Innovation Awards marks a significant milestone as we are gearing up for FRENZ global launch at CES 2023, said Tam Vu, CEO of Earable cum Professor at the University of Colorado.
  • Earable invented FRENZ brainband - the world's most accurate consumer wearable that can track and stimulate brain activity for better sleep, focus, and relaxation.

XORTX Presents New Proof of Concept Data at American Society of Nephrology

Retrieved on: 
Thursday, November 3, 2022
Xanthine oxidase, Kidney, International, Society, Uric acid, Coronavirus, Mouse, University, OXO, Cyst, Analysis, Form, SEC, Nephrology, Diabetes, Hyperuricemia, Growth, GLOBE, Incidence, Fibrosis, Autosome, CEO, Health, DS, Xanthine, Allantoin, Diagnosis, Polycystic kidney disease, Patient, TSX Venture Exchange, Research, Unitary state, University of Colorado Denver School of Public Affairs, Letter, Human, Quality of life, COVID-19, HIV disease progression rates, Life, No, Kidney disease, Urate oxidase, Conference, Abstract, Therapy, Nasdaq, Session, ASN, American Society of Nephrology, Chronic pain, NASDAQ, News, Association, Pharmaceutical industry, Sulfur, Gum arabic, ADPKD, Kidney stone disease, PKD, Creatinine

CALGARY, Alberta, Nov. 03, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce the presentation of a peer-reviewed abstract to be presented November 4, 2022 at the American Society of Nephrology (“ASN”) Annual Conference – Kidney Week.  The abstract presents new discoveries in two species – mouse and rat models of polycystic kidney disease (“PKD”) and reports original work showing the harmful consequence of chronically increased uric acid on both structure and function of kidneys. The Abstract “Raising Serum Uric Acid with a Uricase Inhibitor Worsens PKD in Rat and Mouse models” will be presented during the Session Title: Genetic Diseases of the Kidneys, by Dr. Charles Edelstein of the University of Colorado and Dr. Allen Davidoff, CEO of XORTX.  This presentation will report for the first time, that XORTX's XRx-008 formulation of Xanthine Oxidase inhibitor can substantially and significantly block the increase in kidney size associated with high circulating uric acid in a rodent model of polycystic kidney disease.

Key Points: 
  • The abstract presents the findings of studies conducted at the University of Colorado, by Dr. Charles Edelstein and the PKD research team.
  • Dr. Allen Davidoff, CEO of XORTX, stated, We are pleased to present these important new findings during the ASN Kidney Week 2022.
  • With these results presented today, XORTX now has the information required to prepare and pursue Orphan Drug Designation for XRx-008.
  • At XORTX, we are dedicated to developing medications to improve the quality of life and future health of patients.

XORTX Sponsored American Society of Nephrology Study Abstract Available Online

Retrieved on: 
Tuesday, October 25, 2022
Chronic endothelial injury hypothesis, Growth, TSX Venture Exchange, Incidence, Kidney, Research, Society, News, Mouse, NASDAQ, Nephrology, GLOBE, Life, Coronavirus, American Society of Nephrology, DS, Therapy, Patient, Quality of life, Kidney disease, CEO, Analysis, Conference, SEC, Session, International, University, Health, Polycystic kidney disease, Diagnosis, PCK, Abstract, HIV disease progression rates, Human, Oxidase test, ASN, Fibrosis, COVID-19, Form, Nasdaq, PKD, Diabetic nephropathy, University of Colorado Denver School of Public Affairs, Allantoin, Association, No, Chronic pain, Unitary state, Hyperuricemia, Autosome, Uric acid, Cyst, Letter, OXO, Urate oxidase, Xanthine oxidase, Pharmaceutical industry, Gum arabic, ADPKD, Creatinine, Kidney stone disease

CALGARY, Alberta, Oct. 25, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce online availability of the peer-reviewed abstract to be presented November 4, 2022 at the American Society of Nephrology (“ASN”) Annual Conference – Kidney Week. The abstract presents new discoveries in two species – mouse and rat models of polycystic kidney disease (“PKD”) and reports original work showing the harmful consequence of chronically increased uric acid on both structure and function of kidneys. The Abstract “Raising Serum Uric Acid with a Uricase Inhibitor Worsens PKD in Rat and Mouse models” will be presented during the Session Title: Genetic Diseases of the Kidneys, by Dr. Charles Edelstein of the University of Colorado and Dr. Allen Davidoff of XORTX. 

Key Points: 
  • The abstract presents the findings of studies conducted at the University of Colorado, by Dr. Charles Edelstein and the PKD research team.
  • The aim of this study was to determine whether raising serum uric acid with OXO was associated with worse PKD.
  • We anticipate a further updated information near the time that the abstract for the ASN becomes public.
  • At XORTX, we are dedicated to developing medications to improve the quality of life and future health of patients.

Pluralsight Appoints Michael Agresta as Chief Financial Officer

Retrieved on: 
Monday, October 24, 2022
CFO, Java transaction service, Deloitte, Growth, Business administration, Machine learning, China Executive Leadership Academy in Pudong, Artificial intelligence, Senior, Technology, University, Marketing, Industry, CEO, University of Colorado Denver School of Public Affairs, Accounting, Head, Bachelor, Data science, Marketo, Leadership, Management, Finance, Pluralsight

SILICON SLOPES, Utah, Oct. 24, 2022 /PRNewswire/ -- Pluralsight, the technology workforce development company, today announced that Michael Agresta has officially been appointed as Chief Financial Officer.

Key Points: 
  • SILICON SLOPES, Utah, Oct. 24, 2022 /PRNewswire/ -- Pluralsight, the technology workforce development company, today announced that Michael Agresta has officially been appointed as Chief Financial Officer.
  • Agresta joined Pluralsight as Senior Vice President of Finance in January 2022 and has been serving as the interim CFO since June of this year.
  • "As we look toward Pluralsight's next phase of growth, I am excited to welcome Mike Agresta to the Executive Leadership Team," said Aaron Skonnard, co-founder and CEO of Pluralsight.
  • I am confident that Mike will provide strong leadership to the company, leveraging his extensive financial, operational and strategic experience."